| 1 | [SID49730988] | Active | IC50 | 1.86 | A Cell Based HTS Approach for the Discovery of New Inhibitors of Respiratory syncytial virus (RSV) [AID2391, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 49730988 | | CID | 16010689 | | Outcome | Active | | IC50 | 1.86 [uM] | | BioAssay | A Cell Based HTS Approach for the Discovery of New Inhibitors of Respiratory syncytial virus (RSV) | | AID | 2391 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID99309100] | Active | IC50 | 12.6 | A Cell Based HTS Approach for the Discovery of New Inhibitors of Respiratory syncytial virus (RSV) using synthesized compounds (8) [AID504820, Type: confirmatory] | |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 99309100 | | CID | 16010689 | | Outcome | Active | | IC50 | 12.6 [uM] | | BioAssay | A Cell Based HTS Approach for the Discovery of New Inhibitors of Respiratory syncytial virus (RSV) using synthesized compounds (8) | | AID | 504820 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 3 | [SID99309100] | Active | IC50 | 13.16 | A Cell Based HTS Approach for the Discovery of New Inhibitors of Respiratory syncytial virus (RSV) using purified and synthesized compounds [AID488972, Type: confirmatory] | |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 99309100 | | CID | 16010689 | | Outcome | Active | | IC50 | 13.16 [uM] | | BioAssay | A Cell Based HTS Approach for the Discovery of New Inhibitors of Respiratory syncytial virus (RSV) using purified and synthesized compounds | | AID | 488972 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 4 | [SID49730988] | Active | Potency | 16.3601 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 49730988 | | CID | 16010689 | | Outcome | Active | | Potency | 16.3601 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 5 | [SID49730988] | Active | Potency | 16.3601 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 49730988 | | CID | 16010689 | | Outcome | Active | | Potency | 16.3601 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 6 | [SID49730988] | Active | Potency | 16.3601 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 49730988 | | CID | 16010689 | | Outcome | Active | | Potency | 16.3601 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 7 | [SID49730988] | Active | Potency | 16.3601 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 49730988 | | CID | 16010689 | | Outcome | Active | | Potency | 16.3601 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 8 | [SID49730988] | Active | Potency | 16.3601 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 49730988 | | CID | 16010689 | | Outcome | Active | | Potency | 16.3601 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 9 | [SID49730988] | Active | Potency | 16.3601 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 49730988 | | CID | 16010689 | | Outcome | Active | | Potency | 16.3601 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 10 | [SID24387235] | Active | Potency | 18.3564 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 24387235 | | CID | 16010689 | | Outcome | Active | | Potency | 18.3564 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 11 | [SID24387235] | Active | Potency | 18.3564 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 24387235 | | CID | 16010689 | | Outcome | Active | | Potency | 18.3564 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 12 | [SID24387235] | Active | Potency | 18.3564 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 24387235 | | CID | 16010689 | | Outcome | Active | | Potency | 18.3564 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 13 | [SID24387235] | Active | Potency | 23.1093 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 24387235 | | CID | 16010689 | | Outcome | Active | | Potency | 23.1093 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 14 | [SID24387235] | Active | Potency | 23.1093 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 24387235 | | CID | 16010689 | | Outcome | Active | | Potency | 23.1093 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 15 | [SID24387235] | Active | Potency | 23.1093 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 24387235 | | CID | 16010689 | | Outcome | Active | | Potency | 23.1093 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 16 | [SID99309100] | Active | CC50 | 33.4 | An HTS Cytotoxicity Screen to evaluate New Inhibitors of Respiratory Syncytial Virus (RSV) using synethesized compounds (8) [AID504818, Type: confirmatory] | |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 99309100 | | CID | 16010689 | | Outcome | Active | | CC50 | 33.4 [uM] | | BioAssay | An HTS Cytotoxicity Screen to evaluate New Inhibitors of Respiratory Syncytial Virus (RSV) using synethesized compounds (8) | | AID | 504818 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 17 | [SID99309100] | Active | CC50 | 40.51 | An HTS Cytotoxicity Screen to evaluate New Inhibitors of Respiratory Syncytial Virus (RSV) using purified and synethesized compounds [AID488976, Type: confirmatory] | |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 99309100 | | CID | 16010689 | | Outcome | Active | | CC50 | 40.51 [uM] | | BioAssay | An HTS Cytotoxicity Screen to evaluate New Inhibitors of Respiratory Syncytial Virus (RSV) using purified and synethesized compounds | | AID | 488976 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 18 | [SID49730988] | Active | CC50 | 42.94 | An HTS Cytotoxicity Screen to evaluate New Inhibitors of Respiratory Syncytial Virus (RSV) [AID2410, Type: confirmatory] | |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 49730988 | | CID | 16010689 | | Outcome | Active | | CC50 | 42.94 [uM] | | BioAssay | An HTS Cytotoxicity Screen to evaluate New Inhibitors of Respiratory Syncytial Virus (RSV) | | AID | 2410 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 19 | [SID99309100] | Active | | | A Plaque Reduction Assay to evaluate New Inhibitors of Respiratory Syncytial Virus (RSV) [AID504830, Type: other] | |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 99309100 | | CID | 16010689 | | Outcome | Active | | BioAssay | A Plaque Reduction Assay to evaluate New Inhibitors of Respiratory Syncytial Virus (RSV) | | AID | 504830 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 20 | [SID93616802] | Active | | | A Titer Reduction Assay to evaluate Selected Compounds as new Inhibitors of Respiratory Syncytial Virus (RSV) [AID449732, Type: other] | |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 93616802 | | CID | 16010689 | | Outcome | Active | | BioAssay | A Titer Reduction Assay to evaluate Selected Compounds as new Inhibitors of Respiratory Syncytial Virus (RSV) | | AID | 449732 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 21 | [SID49730988] | Active | IC50 | | uHTS absorbance assay for the identification of compounds that inhibit PHOSPHO1 [AID1565, Type: confirmatory] | phosphoethanolamine/phosphocholine phosphatase isoform 1 [Homo sapiens] [gi:219689097] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 49730988 | | CID | 16010689 | | Outcome | Active | | IC50 | [uM] | | BioAssay | uHTS absorbance assay for the identification of compounds that inhibit PHOSPHO1 | | AID | 1565 | | BioAssay type | confirmatory | | Target | phosphoethanolamine/phosphocholine phosphatase isoform 1 [Homo sapiens] [gi:219689097] | | PubMed | | | Data Table |  |
|
| 22 | [SID24387235] | Unspecified | | | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists [AID485344, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 24387235 | | CID | 16010689 | | Outcome | Unspecified | | BioAssay | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists | | AID | 485344 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 23 | [SID24387235] | Unspecified | | | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists [AID485344, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 24387235 | | CID | 16010689 | | Outcome | Unspecified | | BioAssay | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists | | AID | 485344 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 24 | [SID24387235] | Unspecified | | | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists [AID485344, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 24387235 | | CID | 16010689 | | Outcome | Unspecified | | BioAssay | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists | | AID | 485344 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 25 | [SID24387235] | Unspecified | | | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists [AID485344, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 24387235 | | CID | 16010689 | | Outcome | Unspecified | | BioAssay | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists | | AID | 485344 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 26 | [SID24387235] | Unspecified | | | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists [AID485344, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 24387235 | | CID | 16010689 | | Outcome | Unspecified | | BioAssay | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists | | AID | 485344 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 27 | [SID49730988] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 49730988 | | CID | 16010689 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 28 | [SID49730988] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 49730988 | | CID | 16010689 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 29 | [SID49730988] | Inactive | Potency | 2.5119 | qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion [AID485298, Type: confirmatory] | |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 49730988 | | CID | 16010689 | | Outcome | Inactive | | Potency | 2.5119 [uM] | | BioAssay | qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion | | AID | 485298 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 30 | [SID49730988] | Inactive | Potency | 11.2202 | qHTS Assay for Inhibitors of Influenza NS1 Protein Function [AID2326, Type: confirmatory] | nonstructural protein 1 [Influenza A virus (A/WSN/1933(H1N1))] [gi:194352380] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 49730988 | | CID | 16010689 | | Outcome | Inactive | | Potency | 11.2202 [uM] | | BioAssay | qHTS Assay for Inhibitors of Influenza NS1 Protein Function | | AID | 2326 | | BioAssay type | confirmatory | | Target | nonstructural protein 1 [Influenza A virus (A/WSN/1933(H1N1))] [gi:194352380] | | PubMed | | | Data Table |  |
|
| 31 | [SID49730988] | Inactive | IC50 | | Primary and Confirmatory Screening for Flavivirus Genomic Capping Enzyme Inhibition [AID588689, Type: confirmatory] | Chain A, Crystal Structure Of Dengue-2 Virus Methyltransferase Complexed With S-Adenosyl-L-Homocyste [gi:219689243] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 49730988 | | CID | 16010689 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Primary and Confirmatory Screening for Flavivirus Genomic Capping Enzyme Inhibition | | AID | 588689 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of Dengue-2 Virus Methyltransferase Complexed With S-Adenosyl-L-Homocyste [gi:219689243] | | PubMed | | | Data Table |  |
|
| 32 | [SID49730988] | Inactive | IC50 | | Discovery of Small Molecule Probes for H1N1 Influenza NS1A [AID504329, Type: confirmatory] | nonstructural protein 1 [Influenza A virus (A/California/07/2009(H1N1))] [gi:227977143] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 49730988 | | CID | 16010689 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Discovery of Small Molecule Probes for H1N1 Influenza NS1A | | AID | 504329 | | BioAssay type | confirmatory | | Target | nonstructural protein 1 [Influenza A virus (A/California/07/2009(H1N1))] [gi:227977143] | | PubMed | | | Data Table |  |
|
| 33 | [SID49730988] | Inactive | Potency | | qHTS Assay for Identification of Novel General Anesthetics [AID485281, Type: confirmatory] | Chain A, Horse Spleen Apoferritin [gi:254220970] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 49730988 | | CID | 16010689 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Identification of Novel General Anesthetics | | AID | 485281 | | BioAssay type | confirmatory | | Target | Chain A, Horse Spleen Apoferritin [gi:254220970] | | PubMed | | | Data Table |  |
|
| 34 | [SID24387235] | Inactive | Potency | | qHTS Assay for Identification of Novel General Anesthetics [AID485281, Type: confirmatory] | Chain A, Horse Spleen Apoferritin [gi:254220970] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 24387235 | | CID | 16010689 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Identification of Novel General Anesthetics | | AID | 485281 | | BioAssay type | confirmatory | | Target | Chain A, Horse Spleen Apoferritin [gi:254220970] | | PubMed | | | Data Table |  |
|
| 35 | [SID24387235] | Inactive | Potency | | qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent) [AID1476, Type: confirmatory] | Chain A, Crystal Structure Of Cruzain Covalently Bound To A Purine Nitrile [gi:281307097] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 24387235 | | CID | 16010689 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent) | | AID | 1476 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of Cruzain Covalently Bound To A Purine Nitrile [gi:281307097] | | PubMed | | | Data Table |  |
|
| 36 | [SID24387235] | Inactive | Potency | | qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent) [AID1478, Type: confirmatory] | Chain A, Crystal Structure Of Cruzain Covalently Bound To A Purine Nitrile [gi:281307097] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 24387235 | | CID | 16010689 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent) | | AID | 1478 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of Cruzain Covalently Bound To A Purine Nitrile [gi:281307097] | | PubMed | | | Data Table |  |
|
| 37 | [SID49730988] | Inactive | Potency | | qHTS Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase (LmPK) [AID1721, Type: confirmatory] | pyruvate kinase [Leishmania mexicana mexicana] [gi:290753097] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 49730988 | | CID | 16010689 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase (LmPK) | | AID | 1721 | | BioAssay type | confirmatory | | Target | pyruvate kinase [Leishmania mexicana mexicana] [gi:290753097] | | PubMed | | | Data Table |  |
|
| 38 | [SID49730988] | Inactive | Potency | | qHTS Assay for Activators of Leishmania Mexicana Pyruvate Kinase (LmPK) [AID1722, Type: confirmatory] | pyruvate kinase [Leishmania mexicana mexicana] [gi:290753097] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 49730988 | | CID | 16010689 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Activators of Leishmania Mexicana Pyruvate Kinase (LmPK) | | AID | 1722 | | BioAssay type | confirmatory | | Target | pyruvate kinase [Leishmania mexicana mexicana] [gi:290753097] | | PubMed | | | Data Table |  |
|
| 39 | [SID49730988] | Inactive | | | C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_SinglePoint_HTS_Activity [AID504423, Type: screening] | LANA [Human herpesvirus 8] [gi:312275222] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 49730988 | | CID | 16010689 | | Outcome | Inactive | | BioAssay | C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 504423 | | BioAssay type | screening | | Target | LANA [Human herpesvirus 8] [gi:312275222] | | PubMed | | | Data Table |  |
|
| 40 | [SID49730988] | Inactive | | | TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl) [AID588664, Type: screening] | ABL1 gene product [Homo sapiens] [gi:62362414] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 49730988 | | CID | 16010689 | | Outcome | Inactive | | BioAssay | TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl) | | AID | 588664 | | BioAssay type | screening | | Target | ABL1 gene product [Homo sapiens] [gi:62362414] | | PubMed | | | Data Table |  |
|
| 41 | [SID49730988] | Inactive | | | TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl) [AID588664, Type: screening] | ABL1 gene product [Homo sapiens] [gi:62362414] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 49730988 | | CID | 16010689 | | Outcome | Inactive | | BioAssay | TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl) | | AID | 588664 | | BioAssay type | screening | | Target | ABL1 gene product [Homo sapiens] [gi:62362414] | | PubMed | | | Data Table |  |
|
| 42 | [SID49730988] | Inactive | | | uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay [AID651560, Type: screening] | Low molecular weight phosphotyrosine protein phosphatase [gi:1709543] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 49730988 | | CID | 16010689 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay | | AID | 651560 | | BioAssay type | screening | | Target | Low molecular weight phosphotyrosine protein phosphatase [gi:1709543] | | PubMed | | | Data Table |  |
|
| 43 | [SID49730988] | Inactive | | | uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay [AID651560, Type: screening] | Low molecular weight phosphotyrosine protein phosphatase [gi:1709543] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 49730988 | | CID | 16010689 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay | | AID | 651560 | | BioAssay type | screening | | Target | Low molecular weight phosphotyrosine protein phosphatase [gi:1709543] | | PubMed | | | Data Table |  |
|
| 44 | [SID49730988] | Inactive | | | HTS for Beta-2AR agonists via FAP method [AID504454, Type: screening] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 49730988 | | CID | 16010689 | | Outcome | Inactive | | BioAssay | HTS for Beta-2AR agonists via FAP method | | AID | 504454 | | BioAssay type | screening | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 45 | [SID49730988] | Inactive | | | HTS for Beta-2AR agonists via FAP method [AID504454, Type: screening] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 49730988 | | CID | 16010689 | | Outcome | Inactive | | BioAssay | HTS for Beta-2AR agonists via FAP method | | AID | 504454 | | BioAssay type | screening | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 46 | [SID49730988] | Inactive | | | HTS for Beta-2AR agonists via FAP method [AID504454, Type: screening] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 49730988 | | CID | 16010689 | | Outcome | Inactive | | BioAssay | HTS for Beta-2AR agonists via FAP method | | AID | 504454 | | BioAssay type | screening | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 47 | [SID49730988] | Inactive | | | HTS for Beta-2AR agonists via FAP method [AID504454, Type: screening] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 49730988 | | CID | 16010689 | | Outcome | Inactive | | BioAssay | HTS for Beta-2AR agonists via FAP method | | AID | 504454 | | BioAssay type | screening | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 48 | [SID49730988] | Inactive | Potency | | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor [AID492947, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 49730988 | | CID | 16010689 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor | | AID | 492947 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 49 | [SID49730988] | Inactive | Potency | | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor [AID492947, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 49730988 | | CID | 16010689 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor | | AID | 492947 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 50 | [SID49730988] | Inactive | Potency | | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor [AID492947, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 49730988 | | CID | 16010689 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor | | AID | 492947 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|